tiprankstipranks
Advertisement
Advertisement

REPL Stock Latest News

Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
Class ActionReplimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process
9d ago
REPL
Replimune price target raised to $21 from $20 at JPMorgan
PremiumThe Fly
Replimune price target raised to $21 from $20 at JPMorgan
10d ago
REPL
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
PremiumClass Action
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
15d ago
REPL
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
PremiumClass Action
Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop
18d ago
REPL
Replimune reports Q1 EPS (72c), consensus (77c)
PremiumThe Fly
Replimune reports Q1 EPS (72c), consensus (77c)
20d ago
REPL
Replimune files automatic mixed securities shelf
PremiumThe FlyReplimune files automatic mixed securities shelf
20d ago
REPL
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
Premium
Class Action
Replimune Group Lawsuit Alleges Investors Were Misled Before REPL Stock Drop
22d ago
REPL
Replimune 9.7M share Spot Secondary priced at $12.06
Premium
The Fly
Replimune 9.7M share Spot Secondary priced at $12.06
26d ago
REPL
Replimune Raises $150 Million in Equity Offering
PremiumCompany Announcements
Replimune Raises $150 Million in Equity Offering
26d ago
8K
REPL
Replimune Wins FDA Accelerated Approval for TUDRIQEV
PremiumCompany Announcements
Replimune Wins FDA Accelerated Approval for TUDRIQEV
29d ago
8K
REPL
Replimune price target raised to $20 from $16 at BMO Capital
PremiumThe Fly
Replimune price target raised to $20 from $16 at BMO Capital
29d ago
REPL
Wedbush upgrades Replimune to Outperform following FDA decision
PremiumThe Fly
Wedbush upgrades Replimune to Outperform following FDA decision
30d ago
REPL
Replimune upgraded to Outperform from Neutral at Wedbush
PremiumThe FlyReplimune upgraded to Outperform from Neutral at Wedbush
30d ago
REPL
Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma
Premium
The Fly
Replimune announces FDA accelerated approval of Tudriqev for advanced melanoma
1M ago
REPL
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
Premium
The Fly
Walmart downgraded, Palantir upgraded: Wall Street’s top analyst calls
1M ago
CI
AIP
Replimune upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Replimune upgraded to Outperform from Market Perform at Leerink
1M ago
REPL
These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
PremiumMarket News
These 2 Stocks Just Broke Out — and They Could Go Higher, Say Analysts
1M ago
AXTI
REPL
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
PremiumThe Fly
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
1M ago
CL
BSX
Why Is Replimune (REPL) Stock Up Today?
PremiumMarket News
Why Is Replimune (REPL) Stock Up Today?
1M ago
REPL
Roblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
PremiumThe FlyRoblox downgraded, Quanta Services upgraded: Wall Street’s top analyst calls
1M ago
IP
BSX
Morning Movers: Amazon jumps after quarterly results while Apple slips
Premium
The Fly
Morning Movers: Amazon jumps after quarterly results while Apple slips
1M ago
CVX
ETN
Piper upgrades Replimune to Overweight on better odds of RP1 approval
Premium
The Fly
Piper upgrades Replimune to Overweight on better odds of RP1 approval
1M ago
REPL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >